Medistem Shareholder Update: March 2012 MarketWatch (press release) Launching of RECOVER-ERC Phase II Heart Failure Clinical Trial. In collaboration with the Bakoulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences http://www.bakulev.ru/en/ and ERCell OOO, Medistem has ... |
